Cargando…
Translating tolerogenic therapies to the clinic – where do we stand?
Manipulation of the immune system to prevent the development of a specific immune response is an ideal strategy to improve outcomes after transplantation. A number of experimental techniques exploiting central and peripheral tolerance mechanisms have demonstrated success, leading to the first early...
Autores principales: | Issa, Fadi, Wood, Kathryn J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422982/ https://www.ncbi.nlm.nih.gov/pubmed/22934094 http://dx.doi.org/10.3389/fimmu.2012.00254 |
Ejemplares similares
-
Translating Tolerogenic Therapies to the Clinic – Where Do We Stand and What are the Barriers?
por: Cobbold, Stephen P., et al.
Publicado: (2012) -
Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
por: Marín, Eros, et al.
Publicado: (2018) -
Autoimmune Myopathies: Where Do We Stand?
por: Simon, Jean-Philippe, et al.
Publicado: (2016) -
Where Do We Stand?
Publicado: (1891) -
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
por: Franzin, Rossana, et al.
Publicado: (2020)